Hawkins Richard J — SEC insider filings
SEC reporting owner CIK 1307632. 34 insider filings on record with FilingPulse; latest filed 2026-10-01.
Transaction summary — filings shown
Covers all 34 filings on record, filed 2020-12-17 to 2026-10-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 9 legs across 7 filings — 67,882 shares, $163,339 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 8,000 shares, $26,569 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 51.
- Largest priced transaction: purchase of 48,225 shares @ $2.04 ($98,572) in Savara Inc, filed 2025-06-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Savara Inc (SVRA) | Director | 10 | 1 leg · 48,225 sh · $98,572 | 1 leg · 8,000 sh · $26,569 | 14 |
| LUMOS PHARMA, INC. (LUMO) | Chief Executive Officer, Director | 11 | 4 legs · 4,469 sh · $39,259 | — | 23 |
| CERENOME, INC. (CNSY) | Director | 13 | 4 legs · 15,188 sh · $25,508 | — | 14 |
Insider filings — Hawkins Richard J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-01 | 4 | CERENOME, INC. (CNSY) | Option exercise (M): 921 @ $0 · Option exercise (M): 921 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Option exercise (M): 922 @ $0 · Option exercise (M): 922 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 3,686 (derivative) @ $0 · Grant/award (A): 3,686 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Savara Inc (SVRA) | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2025-11-17 | 4 | Savara Inc (SVRA) | Option exercise (M): 5,860 @ $1.46 · Option exercise (M): 5,860 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 397,794 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | Savara Inc (SVRA) | Purchase (P): 48,225 @ $2.04 | EDGAR |
| 2025-02-20 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 40,122 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Savara Inc (SVRA) | Grant/award (A): 40,000 @ $0 · Sale (S): 8,000 @ $3.32 | EDGAR |
| 2024-12-13 | 4 | LUMOS PHARMA, INC. (LUMO) | Disposition to issuer (D): 753,093 · Disposition to issuer (D): 4,469 · Disposition to issuer (D): 19,624 (derivative) · Disposition to issuer (D): 35,400 (derivative) · Disposition to issuer (D): 35,400 (derivative) · Disposition to issuer (D): 135,000 (derivative) · +2 more | EDGAR |
| 2024-09-17 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 4,000 @ $1.50 | EDGAR |
| 2024-09-16 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 6,285 @ $1.35 | EDGAR |
| 2024-09-12 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 3,650 (derivative) @ $0 | EDGAR |
| 2024-05-10 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 4,902 @ $2.04 · Grant/award (A): 9,804 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | LUMOS PHARMA, INC. (LUMO) | Grant/award (A): 4,500 @ $2.84 · Tax withholding (F): 1,522 @ $2.84 · Grant/award (A): 35,400 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 2,250 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | LUMOS PHARMA, INC. (LUMO) | Tax withholding (F): 690 @ $3.01 | EDGAR |
| 2023-12-15 | 4 | Savara Inc (SVRA) | Grant/award (A): 22,500 @ $0 | EDGAR |
| 2023-12-12 | 4 | Savara Inc (SVRA) | Option exercise (M): 10,841 @ $0.82 · Option exercise (M): 10,841 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | LUMOS PHARMA, INC. (LUMO) | Tax withholding (F): 1,522 @ $3.31 | EDGAR |
| 2023-03-06 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 1 @ $1,000 | EDGAR |
| 2023-02-17 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 20,182 (derivative) @ $0 | EDGAR |
| 2023-02-03 | 4 | LUMOS PHARMA, INC. (LUMO) | Grant/award (A): 4,500 @ $3.52 · Tax withholding (F): 416 @ $3.52 · Grant/award (A): 35,400 (derivative) @ $0 | EDGAR |
| 2022-12-15 | 4 | Savara Inc (SVRA) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2022-12-08 | 4 | Savara Inc (SVRA) | Option exercise (M): 1,172 @ $0.65 · Option exercise (M): 1,172 (derivative) @ $0 | EDGAR |
| 2022-09-23 | 4 | LUMOS PHARMA, INC. (LUMO) | Purchase (P): 2,214 @ $8.84 · Purchase (P): 208 @ $8.80 | EDGAR |
| 2022-09-21 | 4 | LUMOS PHARMA, INC. (LUMO) | Purchase (P): 541 @ $8.65 · Purchase (P): 1,506 @ $8.75 | EDGAR |
| 2022-04-05 | 4 | LUMOS PHARMA, INC. (LUMO) | Tax withholding (F): 1,466 @ $9.23 | EDGAR |
| 2022-02-03 | 4 | LUMOS PHARMA, INC. (LUMO) | Grant/award (A): 4,500 @ $10.02 · Tax withholding (F): 173 @ $10.02 · Grant/award (A): 35,400 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | Savara Inc (SVRA) | Option exercise (M): 728 @ $0.55 · Option exercise (M): 728 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2021-06-11 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 40,000 (derivative) @ $0 · Grant/award (A): 6,336 (derivative) @ $0 | EDGAR |
| 2021-04-05 | 4 | LUMOS PHARMA, INC. (LUMO) | Tax withholding (F): 1,522 @ $12.25 | EDGAR |
| 2021-02-03 | 4 | LUMOS PHARMA, INC. (LUMO) | Grant/award (A): 2,329 @ $0 · Grant/award (A): 28,475 (derivative) @ $0 | EDGAR |
| 2020-12-17 | 4 | Savara Inc (SVRA) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-12-17 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1307632 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs